Wachtell Lipton to Receive Top Honors at the 20th Annual Turnaround Awards
Wachtell Lipton has been has been selected for Out‑of‑Court Restructuring of the Year ($100MM–$500MM) at The M&A Advisor’s 20th Annual Turnaround Awards for our work on bluebird bio’s restructuring, which concluded in June 2025.
A multidisciplinary team spanning several practice areas advised Carlyle in connection with bluebird bio’s restructuring, which concluded with the company’s acquisition by Carlyle and SK Capital amid significant financial challenges.